Vir Biotechnology (VIR) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Vir Biotechnology (VIR) over the last 6 years, with Q3 2025 value amounting to -$1.17.
- Vir Biotechnology's EPS (Weighted Average and Diluted) rose 2500.0% to -$1.17 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.61, marking a year-over-year increase of 790.82%. This contributed to the annual value of -$3.83 for FY2024, which is 1653.62% up from last year.
- Vir Biotechnology's EPS (Weighted Average and Diluted) amounted to -$1.17 in Q3 2025, which was up 2500.0% from -$0.8 recorded in Q2 2025.
- In the past 5 years, Vir Biotechnology's EPS (Weighted Average and Diluted) registered a high of $3.94 during Q4 2021, and its lowest value of -$1.56 during Q3 2024.
- In the last 5 years, Vir Biotechnology's EPS (Weighted Average and Diluted) had a median value of -$0.8 in 2025 and averaged -$0.19.
- In the last 5 years, Vir Biotechnology's EPS (Weighted Average and Diluted) skyrocketed by 56352.94% in 2021 and then tumbled by 22608.7% in 2022.
- Vir Biotechnology's EPS (Weighted Average and Diluted) (Quarter) stood at $3.94 in 2021, then plummeted by 119.04% to -$0.75 in 2022, then dropped by 14.67% to -$0.86 in 2023, then rose by 10.74% to -$0.77 in 2024, then plummeted by 52.41% to -$1.17 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$1.17 for Q3 2025, versus -$0.8 for Q2 2025 and -$0.88 for Q1 2025.